Hypergraph is more powerful. Transform unstructured text into structured knowledge with LLMs. Graphs, hypergraphs, and spatio-temporal extractions — with one command.
Package Insert
[Product Name]
Generic Name: Metformin Hydrochloride Sustained-release Tablets Brand Name: Glucophage English Name: Metformin Hydrochloride Sustained-release Tablets
[Ingredients]
The main active ingredient of this product is metformin hydrochloride, with chemical name: 1,1-Dimethylbiguanide hydrochloride. Molecular Formula: C4H11N5·HCl Molecular Weight: 165.63
[Description]
This product is a white or off-white film-coated tablet, appearing white after removing the coating.
[Indications]
- For type 2 diabetes patients whose blood glucose is not satisfactorily controlled by diet alone, especially those who are obese, may also help with weight reduction.
- Effective for patients with poor response to certain sulfonylureas.
- Can be combined with sulfonylureas or insulin to improve glycemic control.
[Strength]
500mg (calculated as metformin hydrochloride)
[Dosage and Administration]
Oral administration, taken with or after meals. Starting dose is usually once daily, 500mg, taken with dinner. Adjust dosage based on blood glucose and urine glucose, maximum daily dose should not exceed 2000mg. If satisfactory effect is not achieved with once daily 2000mg, may change to twice daily, 1000mg each time.
[Adverse Reactions]
1. Common Adverse Reactions (Incidence >1%)
- Gastrointestinal reactions: Nausea, vomiting, diarrhea, abdominal pain, indigestion, heartburn
- Systemic reactions: Fatigue, headache, dizziness
2. Less Common Adverse Reactions (Incidence 0.1%-1%)
- Skin reactions: Rash, pruritus
- Metabolic abnormalities: Hypoglycemia (when combined with sulfonylureas or insulin)
- Laboratory abnormalities: Elevated lactate dehydrogenase, elevated ALT, elevated AST
3. Rare Adverse Reactions (Incidence <0.1%)
- Lactic acidosis: Manifested as fatigue, nausea, vomiting, abdominal pain, rapid and deep breathing, consciousness disturbance
- Hematologic system: Agranulocytosis, thrombocytopenia
- Allergic reactions: Urticaria, angioneurotic edema
- Hepatobiliary abnormalities: Hepatitis, cholestatic jaundice
4. Adverse Reaction Incidence Statistics
| System | Adverse Reaction | Incidence |
|---|---|---|
| GI | Nausea | 5.2% |
| GI | Vomiting | 2.6% |
| GI | Diarrhea | 4.5% |
| GI | Abdominal pain | 2.1% |
| Systemic | Fatigue | 1.8% |
| Systemic | Headache | 1.5% |
| Skin | Rash | 0.3% |
| Metabolic | Hypoglycemia | 0.2% (monotherapy), 1.5% (combined with sulfonylureas) |
| Hepatobiliary | Elevated transaminases | 0.1% |
| Hematologic | Agranulocytosis | <0.1% |
[Contraindications]
Absolute Contraindications:
- Patients allergic to metformin or other ingredients
- Severe renal insufficiency (eGFR<30ml/min/1.73m²)
- Metabolic acidosis (including diabetic ketoacidosis)
- Severe infection, shock, or other diseases that may cause tissue hypoxia
- Alcoholics
- Patients with uncorrected vitamin B12 or folate deficiency
- Within 48 hours before and after intravascular iodinated contrast agent administration
Relative Contraindications:
- Renal insufficiency (eGFR 30-45ml/min/1.73m²)
- Hepatic insufficiency
- Heart failure
- Severe pulmonary insufficiency
- Pregnant and breastfeeding women
[Precautions]
- Lactic Acidosis: Metformin can cause lactic acidosis, which is rare but can be fatal. If it occurs, discontinue medication immediately and seek medical attention.
- Renal Function Monitoring: Check renal function before and during medication, especially in elderly patients.
- Liver Function Monitoring: Check liver function regularly during medication.
- Blood Glucose Monitoring: Monitor blood glucose and glycated hemoglobin regularly during medication.
- Vitamin B12 Deficiency: Long-term metformin use may reduce vitamin B12 absorption; regular monitoring of vitamin B12 levels is recommended.
- Around Surgery: Discontinue metformin before elective surgery; may resume after renal function recovers postoperatively.